These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9209838)
1. Use of granulocyte colony-stimulating factor in the treatment of acute infectious diseases. Stoltz DA; Bagby GJ; Nelson S Curr Opin Hematol; 1997 May; 4(3):207-12. PubMed ID: 9209838 [TBL] [Abstract][Full Text] [Related]
2. Recombinant methionyl human granulocyte colony-stimulating factor for the prevention and treatment of non-neutropenic infectious diseases. Daifuku R; Andresen J; Morstyn G J Antimicrob Chemother; 1993 Jul; 32 Suppl A():91-7. PubMed ID: 7691789 [TBL] [Abstract][Full Text] [Related]
3. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients. Root RK; Dale DC J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506 [TBL] [Abstract][Full Text] [Related]
4. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants]. Lehrnbecher T Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663 [TBL] [Abstract][Full Text] [Related]
5. A randomized, double-masked, placebo-controlled trial of recombinant granulocyte colony-stimulating factor administration to preterm infants with the clinical diagnosis of early-onset sepsis. Miura E; Procianoy RS; Bittar C; Miura CS; Miura MS; Mello C; Christensen RD Pediatrics; 2001 Jan; 107(1):30-5. PubMed ID: 11134430 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic use of cytokines to modulate phagocyte function for the treatment of infectious diseases: current status of granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and interferon-gamma. Hübel K; Dale DC; Liles WC J Infect Dis; 2002 May; 185(10):1490-501. PubMed ID: 11992286 [TBL] [Abstract][Full Text] [Related]
7. Comparison of recombinant granulocyte colony-stimulating factor, recombinant human granulocyte-macrophage colony-stimulating factor and placebo for treatment of septic preterm infants. Ahmad A; Laborada G; Bussel J; Nesin M Pediatr Infect Dis J; 2002 Nov; 21(11):1061-5. PubMed ID: 12442030 [TBL] [Abstract][Full Text] [Related]
8. Myeloid colony-stimulating factors: use in the newborn. Sreenan C; Osiovich H Arch Pediatr Adolesc Med; 1999 Sep; 153(9):984-8. PubMed ID: 10482217 [TBL] [Abstract][Full Text] [Related]
9. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer. Liang DC Paediatr Drugs; 2003; 5(10):673-84. PubMed ID: 14510625 [TBL] [Abstract][Full Text] [Related]
10. Is G-CSF safe and useful in the treatment of infectious diseases in the non-neutropenic host? Pajkrt D; van Deventer SJ Intensive Care Med; 1997 Jan; 23(1):1-2. PubMed ID: 9037632 [No Abstract] [Full Text] [Related]
11. Granulocyte colony-stimulating factor (G-CSF) in the mechanism of human ovulation and its clinical usefulness. Makinoda S; Hirosaki N; Waseda T; Tomizawa H; Fujii R Curr Med Chem; 2008; 15(6):604-13. PubMed ID: 18336275 [TBL] [Abstract][Full Text] [Related]
12. A new bioassay for human granulocyte colony-stimulating factor (hG-CSF) using murine myeloblastic NFS-60 cells as targets and estimation of its levels in sera from normal healthy persons and patients with infectious and hematological disorders. Shirafuji N; Asano S; Matsuda S; Watari K; Takaku F; Nagata S Exp Hematol; 1989 Feb; 17(2):116-9. PubMed ID: 2463930 [TBL] [Abstract][Full Text] [Related]
13. Role of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the treatment of patients with HIV infection. Frumkin LR Curr Opin Hematol; 1997 May; 4(3):200-6. PubMed ID: 9209837 [TBL] [Abstract][Full Text] [Related]
14. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases. Hübel K; Dale DC; Engert A; Liles WC J Infect Dis; 2001 Jan; 183(2):321-328. PubMed ID: 11112098 [TBL] [Abstract][Full Text] [Related]
15. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group. Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455 [TBL] [Abstract][Full Text] [Related]
16. Clinical studies of granulocyte colony stimulating factor (G-CSF). Scarffe JH; Kamthan A Cancer Surv; 1990; 9(1):115-30. PubMed ID: 1703454 [TBL] [Abstract][Full Text] [Related]